---------------------------- Original Message ---------------------------- Subject: Fwd: AADA rapid response team convinces Aetna to clarify policy on accreditation for in-office pathology labs From: blondi33...@aol.com Date: Tue, May 8, 2012 3:57 pm To: nic...@dlcjax.com --------------------------------------------------------------------------
-----Original Message----- From: nfe1244 <nfe1...@aol.com> To: seaglstein <seaglst...@gmail.com>; pam <p...@dlc.net>; blondi33331 <blondi33...@aol.com> Sent: Sun, May 6, 2012 9:06 am Subject: Fwd: AADA rapid response team convinces Aetna to clarify policy on accreditation for in-office pathology labs good news! -----Original Message----- From: American Academy of Dermatology Association <nore...@aadassociation.org> To: N. Fred Eaglstein; DO; FAAD <nfe1...@aol.com> Sent: Fri, May 4, 2012 5:58 pm Subject: AADA rapid response team convinces Aetna to clarify policy on accreditation for in-office pathology labs If you can't see the images in this email, please click here. This weekâs headlines: Indoor tanning bed labeling legislation introduced, fails to include FDA reclassification House and Senate Committees continue working on prescription drug, medical device legislation AADA provides comments to the FDA regarding biosimilars AADA rapid response team convinces Aetna to clarify policy on accreditation for in-office pathology labs Dermatology societies to collaboratively share recently approved AUC for Mohs surgery with payers Vermont becomes second state in the nation to ban tanning for minors California patient safety bill moves swiftly through state assembly Cosmetic tax proposals stripped from California bills Tanning bill endorsed by Missouri House of Representatives Mississippi enacts ÂPatientÂs Right to Informed Health Care Choices Act Maryland enacts board certification disclosure requirements SkinPAC to host fundraiser in Chicago Register now for the 2012 AADA Legislative Conference, Sept. 9  11, Washington D.C. Congressional action Indoor tanning bed labeling legislation introduced, fails to include FDA reclassification On April 19, Sens. Jack Reed (D-R.I.) and Johnny Isakson (R-Ga.) introduced S. 2301, the Tanning Transparency and Notification Act of 2012 which calls on the FDA to enhance indoor tanning bed labeling requirements based on recommendations the agency made as a result of the TAN Act of 2006. The AADA has been working closely with Sen. ReedÂs office to introduce a Senate companion bill to H.R. 1676, the Tanning Bed Cancer Control Act, which calls on the Food and Drug Administration (FDA) to reclassify indoor tanning beds, however Sen. Reed introduced his new Senate legislation removing the AADA-supported FDA reclassification language and leaving only the enhanced labeling portion of the bill. The AADA sent a letter to both senators stating the importance of including language calling on the FDA to reclassify tanning beds, in addition to the enhanced labeling requirements that, alone, do little to deter the use of indoor tanning beds. House and Senate committees continue working on prescription drug, medical device legislation The House Energy & Commerce Committee and the Senate Health, Education, Labor, and Pensions (HELP) Committee are working on a bipartisan effort to reauthorize prescription drug and medical device user fee legislation. The resulting bills are expected to come to the House and Senate floors for action sometime in June. Both the House and Senate draft bills include language to address the ongoing prescription drug shortages that physicians across the country are facing and propose solutions to mitigate future shortages. Additionally, the Senate HELP Committee version currently includes legislation (S. 2301) introduced by Sens. Jack Reed (D-R.I.) and Johnny Isakson (R-Ga.) calling on the FDA to enhance indoor tanning bed labeling requirements based on the agencyÂs recommendations (see story above). As the Committee process moves forward, the AADA is monitoring the legislation and urging Congress to also include language calling on the FDA to reclassify indoor tanning beds. Federal agency focus AADA provides comments to the FDA regarding biosimilars On May 11, the Food and Drug Administration will convene a public hearing regarding biosimilars. The hearing will include conversations on naming, labeling, and pharmacovigilance of these new therapies. In anticipation of the hearing, the AADA has submitted comments to the agency highlighting our continued concerns regarding naming and pharmacoviligance issues. The Academy urges the agency to provide unique non-proprietary names for all biosimilars to reduce any confusion with the reference biologic products. An update on the May 11 meeting will appear in the next issue of Dermatology Advocate. Private payer activity AADA rapid response team convinces Aetna to clarify policy on accreditation for in-office pathology labs Aetna has assured the Academy that dermatology practices with in-office laboratories will be exempted from a recently announced policy requiring practices to be both Clinical Laboratory Improvement Amendments (CLIA) certified and College of American Pathologists (CAP) accredited to receive payment for surgical pathology services. The Academy took the lead on this issue and has been working closely with Aetna since early April to address concerns about the recent change. As a result, Aetna has agreed that dermatologists do not need to provide additional accreditation documentation. Aetna expects to provide written notification to affected practices in the next few weeks. Dermatology societies to collaboratively share recently approved AUC for Mohs surgery with payers The Academy is collaborating with the American College of Mohs Surgery, American Society for Dermatologic Surgery Association, and American Society for Mohs Surgery to engage in an ongoing dialogue with payers about the recently approved Appropriate Use Criteria for Mohs surgery (Mohs AUC). Next week, the societies will begin this dialogue by sending a joint letter to Novitas Solutions, Inc. (aka Highmark Medicare Services, Inc.) which will provide context for interpreting the Mohs AUC, and communicate how the Mohs AUC support the clinical indications for Mohs surgery, which will serve to preserve its use for our patients. This coordinated effort will help minimize misinterpretation or misuse of the AUC. The Mohs AUC have been submitted for publication to the Journal of the American Academy of Dermatology and Dermatologic Surgery and are posted to the AcademyÂs website. Members of the Academy and collaborating organizations are encouraged to review the Mohs AUC and complete the online survey to provide feedback on what educational resources would be helpful to them in implementing the Mohs AUC in their practices, and to provide comments on areas for consideration in future updates of the Mohs AUC. State policy roundup Vermont becomes second state in the nation to ban tanning for minors On May 2, Vermont became the second state in the nation to prohibit the use of tanning devices by children and teens under the age of 18. The AADA and Vermont Dermatological Society (VDS) commended the state legislature for taking the lead on this important public health issue. Vermont was one of nearly 25 states considering legislation related to regulation of the indoor tanning industry and minors access this session, and the second state after Utah to enact a bill this year. The AADA and VDS hope VermontÂs leadership will serve as a catalyst for other states with pending legislation that could take action before the end of their 2012 legislative sessions, including Massachusetts, Rhode Island, New York, New Jersey, Ohio, North Carolina, and Pennsylvania. California patient safety bill moves swiftly through state assembly On April 26, the California State Assembly unanimously passed Assembly Bill 1548, cosponsored by the American Society for Dermatologic Surgery Association (ASDSA) and the California Society of Dermatology and Dermatologic Surgery (CalDerm), by a vote of 71 to zero. The bill, which the AADA supported via written comments, will now move on to the California State Senate for further consideration. AB 1548 would increase financial penalties for corporate practice of medicine. The bill, as previously reported here, was passed by the full state legislature on two previous occasions and vetoed by then-Governor Arnold Schwarzenegger. This yearÂs legislation has been moving swiftly through the legislative process. AADA will continue to support ASDSA and CalDerm in this effort. Cosmetic tax proposals stripped from California bills Last week, two pieces of legislation were amended to remove language that would have applied California state sales tax to cosmetic medical procedures. The AADA and the American Society for Dermatologic Surgery Association jointly commented in opposition to AB 2540 and AB 1963 prior to hearings in Assembly policy committees last month. The AADA will remain vigilant with the ASDSA and the California Society of Dermatology and Dermatologic Surgery to ensure these proposals do not resurface this year. Tanning bill passes Missouri House of Representatives On April 30, the Missouri House of Representatives passed House Bill 1475 by a vote of 91 to 56. The legislation would require minors under the age of 17 to obtain parental consent before using a tanning bed. The bill is now being sent to the state senate for consideration. The Missouri Dermatological Society Association (MDSA) has been working tirelessly for several years, with the support of the AADA, to pass legislation to better regulate the tanning industry in the state, including provisions related to minors access. HB 1475 is the first stand-alone bill in two years to proceed to this point in the legislative process. AADA will continue to support the efforts of the MSDA on this issue. Mississippi enacts ÂPatientÂs Right to Informed Health Care Choices Act On April 18, Mississippi Gov. Haley Barbour signed Senate Bill 2670, "The Patient's Right to Informed Health Care Choices Act." The AADA and the Mississippi Dermatological Society supported SB 2670 and its companion bill, House Bill 899, early in the legislative process with written comments. The legislation is based on the American Medical AssociationÂs model bill on truth in advertising, developed by the Scope of Practice Partnership, and helps to ensure that patients are promptly and clearly informed of the actual training and qualifications of their health care practitioners. The bill requires in part that all advertisements for health care services are free from deceptive and misleading information and identify the type of license held by the provider(s). In addition, health care practitioners are required to post in their office and affirmatively communicate their specific license to all patients. The new law is effective July 1. Maryland enacts board certification disclosure requirements At the close of the Maryland legislative session last month, the General Assembly unanimously passed Senate Bill 395 and House Bill 957, requiring all health occupation boards in the state to submit information to the legislature by the end of 2012 on exactly what regulations or policies currently exist for their licensees related to advertising. In addition, the legislation requires any physician who advertises board certification to disclose his or her specialty or subspecialty field of certification and the name of the certifying board. Only physicians with certification from approved boards will be permitted to advertise board certification. Gov. OÂMalley signed both pieces of legislation on May 2, and the new law will take effect on Oct. 1. Political affairs  SkinPAC SkinPAC to host fundraiser in Chicago SkinPAC will be having a fundraiser in Chicago on Saturday, May 5, 2012 from 7 to 9 p.m. in a private suite, room 3712, at the Fairmont Hotel. This reception will coincide with the American College of Mohs Surgery Annual Meeting, but is not associated with the organization; however Mohs surgeons have been invited to attend. The event is being hosted by Brett Coldiron, MD, Brent Moody, MD, and Pat Davey, MD. The host committee is asking for a $500 contribution to attend the event. Cocktails and hors dÂoeuvres will be served. If you would like to attend, please RSVP to Sam Hewitt, the AADAÂs manager of political affairs, at (202) 712-2609, or by email at shew...@aad.org. SkinPACÂs political purpose is to solicit and receive contributions to be used to make political campaign expenditures to those candidates for federal elective office, and other federal political committees, who demonstrate understanding and interest in the views and goals of the American Academy of Dermatology Association. Contributions to SkinPAC are not deductible as charitable contributions for federal income tax purposes. SkinPAC cannot accept contributions from corporate accounts. All AADA members have the right to refuse to contribute without reprisal. Federal law prohibits us from accepting contributions from foreign nationals. Federal law requires us to use our best efforts to collect and report the name, physical address, occupation, and the name of the employer of individuals whose contributions exceed $200 in a calendar year. Upcoming events Register now for the 2012 AADA Legislative Conference, Sept 9  11, Washington, D.C. The AADA is pleased to invite the entire Academy membership to register for the 2012 Legislative Conference, Sept. 9  11 at the Crystal Gateway Marriott, 10 minutes from the US Capitol. The Legislative Conference is a unique blend of didactic and interactive advocacy training sessions, political debate and the direct lobbying of your members of Congress. Conference attendees learn about critical health policy issues from national health policy experts, political insiders, and AADA advocacy leaders. A keynote address will be delivered by former CMS administrator, Mark McClellan, MD, PhD. However, the most powerful aspect of the Legislative Conference is your ability to build and strengthen personal relationships with your members of Congress and their staff. If you no longer wish to receive future emails from the Academy, please click here.
-----Original Message----- From: American Academy of Dermatology Association <[1]nore...@aadassociation.org> To: N. Fred Eaglstein; DO; FAAD <[2]nf= e1...@aol.com> Sent: Fri, May 4, 2012 5:58 pm Subject: AADA rapid response team convinces Aetna to clarify policy on ac= creditation for in-office pathology labs If you can't see the images in this email, please <= A style="COLOR: #cccccc; TEXT-DECORATION: underline; text-underline: si= ngle" href="http://lyris.neton-line.com/t/46093/2710654/1531/0/"; target =_blank>click here. [3][test.neton-line.c=] This weekâ= s headlines: * [4]Indoor tanning bed labeling legislation introduced, fa= ils to include FDA reclassification * [5]House and Senate Committees continue working on prescr= iption drug, medical device legislation * [6]AADA provides comments to the FDA regarding biosimilar= s * [7]AADA rapid response team convinces Aetna to clarify po= licy on accreditation for in-office pathology labs * [8]Dermatology societies to collaboratively share recentl= y approved AUC for Mohs surgery with payers * [9]Vermont becomes second state in the nation to ban tann= ing for minors * [10]California patient safety bill moves swiftly through s= tate assembly * [11]Cosmetic tax proposals stripped from California bills<= /A> * [12]Tanning bill endorsed by Missouri House of Representat= ives * [13]Mississippi enacts ÂPatientÂs Right to Info= rmed Health Care Choices Act * [14]Maryland enacts board certification disclosure requir= ements * [15]SkinPAC to host fundraiser in Chicago * [16]Register now for the 2012 AADA Legislative Conference= , Sept. 9  11, Washington D.C. Congressional action Indoor tanni= ng bed labeling legislation introduced, fails to include FDA reclassifica= tion On April 19, Sens. Jack Reed (D-R.I.) and Johnny Isakson (R-Ga.) introduc= ed [17]S. 2301, the Tanning Transparency and Notification Act of 2= 012 which calls on the FDA to enhance indoor tanning bed labeling require= ments based on recommendations the agency made as a result of the TAN Act= of 2006. The AADA has been working closely with Sen. ReedÂs office = to introduce a Senate companion bill to H.R. 1676, the Tanning Bed Cancer= Control Act, which calls on the Food and Drug Administration (FDA) to re= classify indoor tanning beds, however Sen. Reed introduced his new Senate= legislation removing the AADA-supported FDA reclassification language an= d leaving only the enhanced labeling portion of the bill. The AADA sent a= [18]letter to both senators stating the importance of including la= nguage calling on the FDA to reclassify tanning beds , in addition to the enhanced labeling requirements that, alone, do litt= le to deter the use of indoor tanning beds. House and Senate committees continue working on prescription drug, m edical device legislation The House Energy & Commerce Committee and the Senate Health, Educatio n, Labor, and Pensions (HELP) Committee are working on a bipartisan effor= t to reauthorize prescription drug and medical device user fee legislatio= n. The resulting bills are expected to come to the House and Senate floor= s for action sometime in June. Both the House and Senate draft bills incl= ude language to address the ongoing prescription drug shortages that phys= icians across the country are facing and propose solutions to mitigate fu= ture shortages. Additionally, the Senate HELP Committee version currently= includes [19]legislation (S. 2301) introduced by Sens. Jack Reed = (D-R.I.) and Johnny Isakson (R-Ga.) calling on the FDA to enhance indoor = tanning bed labeling requirements based on the agencyÂs recommendati= ons (see story above). As the Committee process moves forward, the AADA i s monitoring the legislation and urging Congress to also include language calling on the FDA to reclassify indoor tanning= beds. Federal agency focus AADA provides comments to the FDA regarding biosimilars On May 11, the Food and Drug Administration will convene a public hearing= regarding biosimilars. The hearing will include conversations on naming,= labeling, and pharmacovigilance of these new therapies. In anticipation = of the hearing, the AADA has submitted [20]comments to the agency = highlighting our continued concerns regarding naming and pharmacoviliganc= e issues. The Academy urges the agency to provide unique non-proprietary = names for all biosimilars to reduce any confusion with the reference biol= ogic products. An update on the May 11 meeting will appear in the next is= sue of Dermatology Advocate. Private payer activity = AADA rapid response team convinces Aetna to clarify= policy on accreditation for in-office pathology labs Aetna has assured the Academy that dermatology practices with in-office l= aboratories will be exempted from a recently announced policy requiring p= ractices to be both Clinical Laboratory Improvement Amendments (CLIA) cer= tified and College of American Pathologists (CAP) accredited to receive p= ayment for surgical pathology services. The Academy took the lead on this= issue and has been working closely with Aetna since early April to addre= ss concerns about the recent change. As a result, Aetna has agreed that d= ermatologists do not need to provide additional accreditation documentati= on. Aetna expects to provide written notification to affected practices i= n the next few weeks. Dermatology = societies to collaboratively share recently approved AUC for Mohs surgery= with payers The Academy is collaborating with the American College of Mohs Surgery, A= merican Society for Dermatologic Surgery Association, and American Societ= y for Mohs Surgery to engage in an ongoing dialogue with payers about the= recently approved Appropriate Use Criteria for Mohs surgery (Mohs AUC). = Next week, the societies will begin this dialogue by sending a joint lett= er to Novitas Solutions, Inc. (aka Highmark Medicare Services, Inc.) whic= h will provide context for interpreting the Mohs AUC, and communicate how= the Mohs AUC support the clinical indications for Mohs surgery, which wi= ll serve to preserve its use for our patients. This coordinated effort wi= ll help minimize misinterpretation or misuse of the AUC. The Mohs AUC have been submitted for publ= ication to the Journal of the American Academy of Dermatology an= d Dermatologic Surgery and are posted to the [21]AcademyÂ= s website. Members of the Academy and collaborating organizations are= encouraged to review the Mohs AUC and complete the online survey to prov= ide feedback on what educational resources would be helpful to them in im= plementing the Mohs AUC in their practices, and to provide comments on ar= eas for consideration in future updates of the Mohs AUC. State policy roundup Vermont becomes second state in the nation to ban tanning for minors On May 2, Vermont became the second state in the nation to prohibit the u= se of tanning devices by children and teens under the age of 18. The AADA= and Vermont Dermatological Society (VDS) [22]commended the state = legislature for taking the lead on this important public health issue. Ve= rmont was one of nearly 25 states considering legislation related to regu= lation of the indoor tanning industry and minors access this sessio= n, and the second state after Utah to enact a bill this year. The AADA an= d VDS hope VermontÂs leadership will serve as a catalyst for other s= tates with pending legislation that could take action before the end of t= heir 2012 legislative sessions, including Massachusetts, Rhode Island, Ne= w York, New Jersey, Ohio, North Carolina, and Pennsylvania. California patient safety bill moves swiftly through state assembly< /STRONG> On April 26, the California State Assembly unanimously passed Assembly Bi= ll 1548, cosponsored by the American Society for Dermatologic Surgery Ass= ociation (ASDSA) and the California Society of Dermatology and Dermatolog= ic Surgery (CalDerm), by a vote of 71 to zero. The bill, which the AADA s= upported via written comments, will now move on to the California State S= enate for further consideration. AB 1548 would increase financial penalti= es for corporate practice of medicine. The bill, as previously reported h ere, was passed by the full state legislature on two previous occasions a= nd vetoed by then-Governor Arnold Schwarzenegger. This yearÂs legisl= ation has been moving swiftly through the legislative process. AADA will = continue to support ASDSA and CalDerm in this effort. Cosmetic tax proposals stripped from California bills Last week, two pieces of legislation were amended to remove language that= would have applied California state sales tax to cosmetic medical proced= ures. The AADA and the American Society for Dermatologic Surgery Associat= ion jointly commented in opposition to AB 2540 and AB 1963 prior to heari= ngs in Assembly policy committees last month. The AADA will remain vigila= nt with the ASDSA and the California Society of Dermatology and Dermatolo= gic Surgery to ensure these proposals do not resurface this year. Tanning bill passes Missouri House of Representatives On April 30, the Missouri House of Representatives passed House Bill 1475= by a vote of 91 to 56. The legislation would require minors under the ag= e of 17 to obtain parental consent before using a tanning bed. The bill i= s now being sent to the state senate for consideration. The Missouri Derm= atological Society Association (MDSA) has been working tirelessly for sev= eral years, with the support of the AADA, to pass legislation to better r= egulate the tanning industry in the state, including provisions related t= o minors access. HB 1475 is the first stand-alone bill in two years= to proceed to this point in the legislative process. AADA will continue = to support the efforts of the MSDA on this issue. Mississippi enacts ÂPatientÂs Right to Informed Health Ca re Choices Act On April 18, Mississippi Gov. Haley Barbour signed Senate Bill 2670, "The= Patient's Right to Informed Health Care Choices Act." The AADA and the M= ississippi Dermatological Society supported SB 2670 and its companion bil= l, House Bill 899, early in the legislative process with written comments= . The legislation is based on the American Medical AssociationÂs mod= el bill on truth in advertising, developed by the Scope of Practice Partn= ership, and helps to ensure that patients are promptly and clearly inform= ed of the actual training and qualifications of their health care practit= ioners. The bill requires in part that all advertisements for health care services are free from deceptive and misleading information and identify= the type of license held by the provider(s). In addition, health care pr= actitioners are required to post in their office and affirmatively commun= icate their specific license to all patients. The new law is effective Ju= ly 1. Maryland enacts board certification disclosure requirements At the close of the Maryland legislative session last month, the General = Assembly unanimously passed Senate Bill 395 and House Bill 957, requiring= all health occupation boards in the state to submit information to the l= egislature by the end of 2012 on exactly what regulations or policies cur= rently exist for their licensees related to advertising. In addition, the= legislation requires any physician who advertises board certification to= disclose his or her specialty or subspecialty field of certification and= the name of the certifying board. Only physicians with certification fro= m approved boards will be permitted to advertise board certification. Gov= . OÂMalley signed both pieces of legislation on May 2, and the new l= aw will take effect on Oct. 1. Political affairs  SkinPA= C SkinPAC to host fundraiser in Chicago SkinPAC will be having a fundraiser in Chicago on Saturday, May 5, 2012 f= rom 7 to 9 p.m. in a private suite, room 3712, at the [23]Fairmont Hot= el. This reception will coincide with the American College of Mohs Su= rgery Annual Meeting, but is not associated with the organization; howeve= r Mohs surgeons have been invited to attend. The event is being hosted by= Brett Coldiron, MD, Brent Moody, MD, and Pat Davey, MD. The host committ= ee is asking for a $500 contribution to attend the event. Cocktails and h= ors dÂoeuvres will be served. If you would like to attend, please RS= VP to Sam Hewitt, the AADAÂs manager of political affairs, at (202) = 712-2609, or by email at [24]shewitt@aad.o= rg. SkinPACÂs polit= ical purpose is to solicit and receive contributions to be used to make p= olitical campaign expenditures to those candidates for federal elective o= ffice, and other federal political committees, who demonstrate understand= ing and interest in the views and goals of the American Academy of Dermat= ology Association. Contributions to SkinPAC are not deductible as charitable contributions = for federal income tax purposes. SkinPAC cannot accept contributions from= corporate accounts. All AADA members have the right to refuse to contrib= ute without reprisal. Federal law prohibits us from accepting contributio= ns from foreign nationals. Federal law requires us to use our best effort= s to collect and report the name, physical address, occupation, and the n= ame of the employer of individuals whose contributions exceed $200 in a c alendar year. Upcoming events Register now for the 2012 AADA Legislative Con= ference, Sept 9  11, Washington, D.C. The AADA is pleased to invite the entire Academy membership to [25]reg= ister for the [26]2012 Legislative Conference, Sept. 9  = 11 at the Crystal Gateway Marriott, 10 minutes from the US Capitol. The L= egislative Conference is a unique blend of didactic and interactive advoc= acy training sessions, political debate and the direct lobbying of your m= embers of Congress. Conference attendees learn about critical health poli= cy issues from national health policy experts, political insiders, and AA= DA advocacy leaders. A keynote address will be delivered by former CMS ad= ministrator, Mark McClellan, MD, PhD. However, the most powerful aspect o= f the Legislative Conference is your ability to build and strengthen pers onal relationships with your members of Congress and their staff. [27][test.neton-line.c=] If you no longer wish to receive future emails from the Academy, please <= /FONT>[28]click here. 3D"" 3D"" References 1. 3D"mailto:n 2. 3D"mailto:nfe1...@aol.com"; 3. 3D"http://lyris.neton-line.com/t/46093/271065 4. 3D"http://mail.aol.com/36049-111/aol-6/en-us/Suite.aspx#story 5. 3D"http://mail.aol.com/36049-111/aol-6/en-us/Suite.aspx#story 6. 3D"http://mail.aol.com/36049-111/aol-6/en-us/Suite.aspx#story 7. 3D"http://mail.aol.com/36049-111/aol-6/en-us/Suite.aspx#story 8. 3D"http://mail.aol.com/36049-111/aol-6/en-us/Suite.aspx#story 9. 3D"http://mail.aol.com/36049-111/aol-6/en-us/Suite.aspx#story 10. 3D"http://mail.aol.com/36049-111/aol-6/en-us/Suite.aspx#story 11. 3D"http://mail.aol.com/36049-111/aol-6/en-us/Suite.aspx#story 12. 3D"http://mail.aol.com/36049-111/aol-6/en-us/Suite.aspx#story 13. 3D"http://mail.aol.com/36049-111/aol-6/en-us/Suite.aspx#story 14. 3D"http://mail.aol.com/36049-111/aol-6/en-us/Suite.aspx#story 15. 3D"http://mail.aol.com/36049-111/aol-6/en-us/Suite.aspx#story 16. 3D"http://mail.aol.com/36049-111/aol-6/en-us/Suite.aspx#story 17. 3D"http://lyris.neton-line.com/t/46093/2710654/1532/0/"; 18. 3D"http://lyris.neton-line.com/t/46093/2710654/1533/0/"; 19. 3D"http://lyris.neton-line.com/t/46093/2710654/1532/0/"; 20. 3D"http://lyris.neton-line=/ 21. 3D"http://l=/ 22. 3D"http://lyris.neton-l=/ 23. 3D"http://l=/ 24. 3D"mailto:shew...@aad.org"; 25. file://localhost/tmp/3D 26. 3D"http://lyris.neton-line.com/t/46093/2710654/ 27. 3D"http://lyri=/ 28. 3D"http://lyris.neton-line.com/t/46093/2710654/927/0/";
_______________________________________________ Histonet mailing list Histonet@lists.utsouthwestern.edu http://lists.utsouthwestern.edu/mailman/listinfo/histonet
